GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stomach cancer fight: triple attack before surgery
Disease control Not yet recruitingThis study is testing if a three-part treatment is better than standard chemotherapy for people with a type of stomach or esophagus cancer that can be removed with surgery. Before surgery, patients will get either standard chemotherapy alone or chemotherapy plus low-dose radiatio…
Matched conditions: GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Apr 04, 2026 06:51 UTC
-
New Two-Pronged attack on advanced stomach cancer enters testing
Disease control Not yet recruitingThis study is testing a new combination of two immunotherapy drugs (iparomlimab and tuvonralimab, together called QL1706) with a modified chemotherapy regimen (TFOX) for people with advanced stomach or gastroesophageal junction cancer that is HER2-negative. The goal is to see if …
Matched conditions: GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Apr 03, 2026 14:50 UTC
-
Four-Pronged attack on stomach cancer tested before surgery
Disease control Not yet recruitingThis study is testing a combination of two immunotherapy drugs, one targeted therapy drug, and a standard chemotherapy regimen. The goal is to see if this four-drug combination can shrink tumors enough to allow for surgical removal in patients with a specific type of advanced sto…
Matched conditions: GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC